Literature DB >> 26054669

Short term exposure to ethyl pyruvate has long term anti-inflammatory effects on microglial cells.

Suzana Stanisavljević1, Bojan Jevtić1, Neda Djedović1, Djordje Miljković2.   

Abstract

Ethyl pyruvate (EP) has been increasingly appreciated as an anti-inflammatory and neuroprotective agent with potent pharmacological properties relevant for treatment of various CNS disorders. Microglial cells seem to be particularly sensitive to its effects. In this study, microglial cells were exposed to EP for relatively short periods (10-120min) and inflammatory properties of the cells were determined after 24h of cultivation. Application of EP in the short-term periods inhibited production of interleukin-6, tumor necrosis factor and nitric oxide in microglial cells. At the same time, the effects on cell viability, reactive oxygen species generation and expression of F4/80 and CD40 of microglial cells were minor. NFκB activation was not affected by EP in the cells during the short exposures, thus implying that the observed effect of EP on cytokine and nitric oxide generation was performed in NFκB independent way. Importantly, effects of the short term EP treatment on microglial cells were detected by a real time cell analysis, as well. The observed ability of EP to affect microglial cell function after relatively short time of exposure is relevant for its therapeutic potential against inflammatory disorders of the CNS.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Ethyl pyruvate; Interleukin-6; Microglia; Nitric oxide; Tumor necrosis factor

Mesh:

Substances:

Year:  2015        PMID: 26054669     DOI: 10.1016/j.biopha.2015.03.006

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  2 in total

Review 1.  Ethyl pyruvate, a versatile protector in inflammation and autoimmunity.

Authors:  Ivan Koprivica; Neda Djedovic; Ivana Stojanović; Đorđe Miljković
Journal:  Inflamm Res       Date:  2022-01-09       Impact factor: 4.575

2.  Restraint of Fumarate Accrual by HIF-1α Preserves miR-27a-Mediated Limitation of Interleukin 10 during Infection of Macrophages by Histoplasma capsulatum.

Authors:  Heather M Evans; Destiny F Schultz; Adam J Boiman; Melanie C McKell; Joseph E Qualls; George S Deepe
Journal:  mBio       Date:  2021-11-09       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.